Synopsys Inc
SNPS
$0.00
-0.20%
Synopsys Inc is a leading provider of electronic design automation (EDA) software and intellectual property for the semiconductor industry. It is a dominant player in the EDA market, benefiting from the convergence of systems companies designing chips and semiconductor firms moving up the technology stack.…
SNPS
Synopsys Inc
$0.00
Investment Opinion: Should I buy SNPS Today?
Based on a synthesis of the data, the objective assessment is a Hold. The company's strong long-term fundamentals, market leadership, and revenue growth are compelling. However, the extreme near-term volatility in earnings, high valuation multiples based on trailing metrics, and clear technical downtrend suggest significant risk. Investors should wait for clarity on the sustainability of margins and a stabilization in the stock's price trend before considering a new position.
Sign up to view all
SNPS 12-Month Price Forecast
The data presents a conflicted picture: powerful long-term growth tailwinds are countered by severe near-term operational and market risks. The high probability base case reflects a expectation of muddling through, with the stock requiring time to rebuild investor trust after the significant earnings shock.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Synopsys Inc's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
7 analysts
Implied Upside
—
vs. current price
Analyst Count
7
covering this stock
Price Range
$0 - $0
Analyst target range
No sufficient analyst coverage available. The provided data includes institutional rating actions but lacks consensus target prices, ratings distribution, or earnings estimates from a broad analyst pool. Recent rating actions show a mix of Buy, Neutral, and Equal Weight recommendations from various firms, with Morgan Stanley downgrading from Overweight to Equal Weight in late February 2026.
Bulls vs Bears: SNPS Investment Factors
Synopsys is a fundamentally strong company with a dominant market position and impressive revenue growth, but it faces severe near-term headwinds. The dramatic collapse in quarterly profitability and the stock's sharp technical decline create significant uncertainty. The investment case hinges on whether the Q1 margin weakness is a temporary anomaly or a sign of deeper issues.
Bullish
- Dominant Market Position: Leader in EDA software, critical for semiconductor design and AI infrastructure.
- Strong Revenue Growth: Q1 2026 revenue grew 65.5% YoY, indicating robust demand.
- Healthy Financial Position: Solid liquidity with a 1.62 current ratio and moderate 0.50 debt-to-equity.
- Strong Free Cash Flow: TTM free cash flow of $2.28 billion supports financial flexibility.
Bearish
- Severe Profitability Collapse: Q1 net income margin fell to 2.7% from 19.9% in prior quarter.
- Elevated Valuation Multiples: Trailing P/E of 54.6 and EV/EBITDA of 33.6 are high given earnings drop.
- Sharp Technical Downtrend: Stock down 15.9% in 6 months, trading near 52-week low.
- Weak Relative Performance: Underperformed S&P 500 by 10.96% over the past 3 months.
SNPS Technical Analysis
The stock has experienced significant volatility and a pronounced downtrend over the past six months. From the data provided, the price has fallen from $471.15 on October 2, 2025, to $396.48 on March 31, 2026, representing a 6-month decline of 15.85%. The stock's 52-week range is $365.74 to $651.73, placing the current price near the lower end of this spectrum. Short-term performance has been weak, with the stock down 15.59% over the past three months and 4.23% over the past month. This underperformance is notable against the broader market, as indicated by relative strength figures of -10.96 (3-month) and 1.02 (1-month) compared to the S&P 500. Currently trading at $396.48, the stock is approximately 39% below its 52-week high and only 8.4% above its 52-week low. The price action shows a sharp sell-off in late March 2026, dropping from $428.25 to $396.48 in the final week, indicating persistent selling pressure.
Beta
1.15
1.15x market volatility
Max Drawdown
-41.0%
Largest decline past year
52-Week Range
$366-$652
Price range past year
Annual Return
-9.7%
Cumulative gain past year
| Period | SNPS Return | S&P 500 |
|---|---|---|
| 1m | -6.7% | -4.3% |
| 3m | -17.6% | -4.0% |
| 6m | -15.6% | -2.0% |
| 1y | -9.7% | +22.2% |
| ytd | -17.6% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SNPS Fundamental Analysis
Revenue growth remains robust, with Q1 2026 revenue of $2.41 billion representing a 65.5% year-over-year increase. However, profitability metrics have weakened significantly in the most recent quarter; the net income margin fell to 2.7% in Q1 2026 from 19.9% in Q4 2025, and operating margin declined to 8.4% from 5.4% over the same period. The company maintains a moderate debt-to-equity ratio of 0.50 and a healthy current ratio of 1.62, indicating solid liquidity. Free cash flow generation is strong, with TTM free cash flow of $2.28 billion, and the latest quarterly operating cash flow was $856.8 million. Operational efficiency, as measured by return on equity (ROE), was 4.7% based on the latest key metrics, a sharp decline from levels seen in prior quarters. The quarterly financials show a significant drop in net income to $64.7 million in Q1 2026 from $448.7 million in Q4 2025, raising concerns about near-term earnings pressure.
Quarterly Revenue
$2.4B
2026-01
Revenue YoY Growth
+0.65%
YoY Comparison
Gross Margin
+0.73%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SNPS Overvalued?
Given that net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E ratio is elevated at 54.56, while the forward P/E is a more reasonable 23.25. The high trailing multiple reflects the recent sharp decline in quarterly earnings. Peer comparison data is not available in the provided inputs. Other valuation metrics include a Price/Sales ratio of 10.30 and an EV/EBITDA of 33.63. The PEG ratio is negative at -1.21, which is not meaningful for analysis, likely due to earnings growth rate calculation issues.
PE
54.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~288x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.6x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is the severe and sudden deterioration in profitability, as evidenced by the net income margin plunging from 19.9% in Q4 2025 to 2.7% in Q1 2026. This raises questions about cost control, investment spending, and potential one-time charges that may not be fully resolved. Market and technical risks are elevated, with the stock down 15.9% over six months and trading just 8.4% above its 52-week low, indicating persistent selling pressure and negative sentiment. Furthermore, the company operates in the cyclical semiconductor industry, making it susceptible to downturns in chip design spending. The lack of a broad analyst consensus and a recent high-profile downgrade add to the uncertainty surrounding near-term performance.
FAQ
The paramount risk is the sustainability of profitability, given the net income margin fell from 19.9% to 2.7% in one quarter. Technical risk is high, with the stock near its 52-week low and underperforming the market. Cyclical risk exists from dependence on semiconductor industry health. Finally, sentiment risk is elevated due to analyst downgrades and lack of clear consensus targets.
The 12-month outlook is for a wide trading range with a base case target of $400-$480. The bull case ($500-$580) depends on a swift earnings recovery, while the bear case ($365-$390) could see a test of the 52-week low if problems persist. The most likely scenario is a period of consolidation as the company works to restore investor confidence following the Q1 earnings shock.
Valuation is mixed. Based on trailing earnings, it appears overvalued with a P/E of 54.6, reflecting the recent earnings plunge. However, the forward P/E of 23.3 is more reasonable for a growth software company. The high Price/Sales ratio of 10.3 and EV/EBITDA of 33.6 suggest the market is still pricing in strong future growth, but these multiples are vulnerable if profitability does not rebound.
Currently, SNPS is a Hold, not a clear buy. The company's dominant position and 65.5% YoY revenue growth are positive, but the severe collapse in Q1 2026 net income (down 85% sequentially) creates too much near-term risk. The stock is also in a strong downtrend, down 15.9% over six months. Investors should wait for evidence of sustained profitability recovery before considering a new purchase.
SNPS is primarily suitable for long-term investors with high risk tolerance who can look past near-term volatility. The short-term outlook is too uncertain due to the earnings collapse and technical downtrend. Long-term investors can bank on the company's essential role in semiconductor and AI development, but must be prepared for significant price swings as the margin story unfolds over the next several quarters.